• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Mechanism of Chronic Stress-induced Reduced Atherosclerotic Medial Area and Increased Plaque Instability in Rabbit Models of Chronic Stress.
CONCLUSIONS: Rabbit models of chronic stress were successfully established by applying both social stress and physical stress for 8 weeks. Chronic stress can reduce AS tunica media and accelerate plaque instability by promoting apoptosis and neovascularization. PMID: 29336364 [PubMed - in process]
Source: Chinese Medical Journal - January 19, 2018 Category: General Medicine Authors: Yu ZM, Deng XT, Qi RM, Xiao LY, Yang CQ, Gong T Tags: Chin Med J (Engl) Source Type: research

Burden of Atrial Fibrillation in M āori and Pacific People in New Zealand: A Cohort Study
ConclusionAF screening and stroke thromboprophylaxis in Māori and Pacific people could start below the age of 65 years in NZ.
Source: Internal Medicine Journal - October 16, 2017 Category: Internal Medicine Authors: Yulong Gu, Robert N Doughty, Ben Freedman, John Kennelly, Jim Warren, Matire Harwood, Richard Hulme, Chris Paltridge, Ruth Teh, Anna Rolleston, Natalie Walker Tags: Original Article Source Type: research

Dodecafluoropentane Improves Neurological Function Following Anterior Ischemic Stroke
This study investigated shortened dosage schedules of DDFPe in nonstandard posterior (NSTND) strokes following occlusions of the posterior cerebral arteries. DDFPe given at shortened schedules of 30 or 60-min injection intervals will reduce neurological deficits, percent stroke volume (%SV), and serum glutamate levels in NSTND ischemic strokes. New Zealand White rabbits (N = 26) were randomly placed into three groups: A (n = 9) controls given saline injections every 60 min, B (n = 9) 2 % DDFPe given IV every 30 min, and C (n = 8) DDFPe every 60 min. Injections began 1 h after embolization. Groups were subdivid...
Source: Molecular Neurobiology - July 13, 2017 Category: Neurology Source Type: research

Trends in New Zealand stroke thrombolysis treatment rates.
CONCLUSIONS: There have been improvements in stroke thrombolysis rates and treatment delays in New Zealand hospitals since the institution of the National Stroke Network thrombolysis register. The Network will continue to adjust key performance indicators, and stroke thrombolysis targets for individual DHBs have been increased to 8% for 2017 and 10% for 2018. PMID: 28384147 [PubMed - in process]
Source: New Zealand Medical Journal - April 8, 2017 Category: Journals (General) Tags: N Z Med J Source Type: research

Stroke thrombolysis in New Zealand: data from the first 6 months of the New Zealand Thrombolysis Register.
Authors: Joshi P, Fink J, Barber PA, Davis A, Lanford J, Seymour A, Wright P, Busby W, Abernethy G, Ranta AA Abstract The New Zealand National Stroke Network introduced a National Stroke Thrombolysis Register on the first of January 2015 to assist with quality assurance and continuous service improvement. In the first 6 months, there were 179 [75 women, mean (SD) age 69.9 (14) years] treated with stroke thrombolysis out of a total of 2,796 ischaemic stroke patients, giving a national thrombolysis rate of 6.4%. The median [Inter-quartile range (IQR)] onset-to-treatment time was 154 (125-190) minutes, and the median ...
Source: New Zealand Medical Journal - July 25, 2016 Category: Journals (General) Tags: N Z Med J Source Type: research

Potential gains and costs from increasing access to thrombolysis for acute ischemic stroke patients in New Zealand hospitals
ConclusionWhile thrombolysis is a cost‐effective treatment in New Zealand, resources should be devoted to campaigns, both within hospitals and in the community, to increase coverage.
Source: International Journal of Stroke - November 10, 2013 Category: Neurology Authors: Braden Te Ao, Paul Brown, John Fink, Mark Vivian, Valery Feigin Tags: Research Source Type: research

Pages: 1  2  3  4  5